infiniDome Delivers GPS Monitoring and Protection Solution to Israel Railways
16.2.2021 11:05:00 EET | Business Wire | Press release
infiniDome Ltd ., The GPS Security Company, today announces participation with Israeli partner, Focus Telecom, in a new country-wide project with Israel Railways. The project involves deployment by Focus Telecom of GPS repeaters at more than 30 railway stations across Israel, providing accurate, location-based service indoors at all locations for a new Israel Railways ticketing app. A critical component of the project is a monitoring service that detects and provides alerts of any GPS disruption or interference in real time, as they are identified. This is facilitated by infiniDome’s IoT GPSensors and its cloud-based GPS monitoring service, infiniCloud.
“Incorporating infiniDome’s proven resilient PNT capability to monitor and protect such a critical GPS service is a necessary enhancement for government designated critical infrastructures,” said Ehud Sharar, Focus Telecom CEO.
infiniDome’s monitoring technology for critical assets detects and alerts operators of threats and disruptions of the essential GPS signals. These threats can originate from both malicious or natural causes.
“GPSensor IoT technology combined with our infiniCloud GPS security cloud assures real-time alerts about jamming attacks. All GPS signal data and its assured integrity are available as real time data so Israel Railways can react immediately and reduce downtime of the network,” said Omer Sharar, infiniDome CEO.
Israel Railways is the cornerstone of Israeli critical infrastructure. In 2018, Israel National Railway carried 68 million passengers. This same infiniDome GPS monitoring and protection technology is now available to defend critical infrastructure assets worldwide.
About Focus Telecom
Focus Telecom is a global provider of time synchronization solutions since 1995, offering consulting, cyber defense and synchronization solutions. Our end-to-end timing solutions generate, distribute and apply precise time for multiple industries, including Communications, Government/Security, Finance/IT, and Industry/Infrastructure. We enable our customers to build more reliable networks and systems supporting today’s precise timing standards. Visit https://www.focus-telecom.com.
About infiniDome, Ltd.
infiniDome, the GPS Security Company, provides front-end cyber solutions protecting wireless communications from jamming attacks. infiniDome’s GPS protection solutions are tailored for defending the GPS systems which are at the heart of drones and other unmanned systems, vehicle fleets and critical networks as well as defense applications. Visit www.infinidome.com.
Note to editors: The Israel Railways organization name is the property Israel Railways.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210216005363/en/
Contact information
Kristi Furrer
infiniDome, Ltd
303-525-0924
kristi@infinidome.com
info@infinidome.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Viz.ai Expands into Neurodegenerative Disease with Cortechs.ai Collaboration9.7.2026 16:00:00 EEST | Press release
Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a collaboration with Cortechs.ai, a global leader in neuroimaging and quantitative analysis solutions, to integrate Cortechs.ai's NeuroQuant and NeuroQuant MS suite into the Viz.ai platform, expanding access to quantitative neuroimaging for hospitals and health systems across the U.S. This partnership marks Viz.ai's expansion into neurodegenerative disease, growing Viz Neuro Suite beyond its already market-leading neuro offerings. The collaboration will begin with a focus on multiple sclerosis (MS), integrating quantitative MRI analysis from NeuroQuant MS directly into Viz.ai's care coordination workflow, giving clinicians both the quantitative precision and the coordination infrastructure needed to identify and manage MS patients at scale. “Viz.ai's core mission has always been to increase access to life-saving treatments. It’s about getting the right information to the right care tea
Orca Security Report: 99.9% of Fixable AI Vulnerabilities Remain Unpatched as AI Moves Into Production9.7.2026 16:00:00 EEST | Press release
Orca Security, a leader in cloud and AI security, today released its 2026 State of AI Security Report, offering a first-hand view into how AI is being deployed across more than 1,200 production cloud environments. The findings show AI is no longer limited to isolated pilots or developer experiments. Organizations are embedding AI into production applications, cloud services, and autonomous workflows faster than security programs can adapt. More than half (56%) of organizations have already deployed AI agents into production, while 51% use AI to build custom applications. At the same time, Orca found that 81% of organizations run vulnerable AI packages, and 99.9% of fixable AI vulnerabilities remain unpatched, highlighting how quickly AI has become operational infrastructure without corresponding security maturity. The report also reveals that AI environments are rapidly becoming more interconnected and business critical. Among organizations adopting AI, 64% now run vector databases, 55
Echodyne Opens New Manufacturing Facility to Meet Surging Global Demand for Advanced MESA® Radar9.7.2026 16:00:00 EEST | Press release
As governments around the world accelerate investment in counter-unmanned aircraft systems (C-UAS) and short-range air defense, Echodyne today announced the opening of a new advanced radar manufacturing facility in Washington State, significantly expanding its manufacturing capacity to meet rapidly growing demand from U.S. and allied customers. With millions of drones manufactured and used by both sides in the Russian War in Ukraine, the need for enhanced safety for defense, national security, and critical infrastructure assets grows with every successful strike and interception. The low cost and high utility of drones dramatically alters the need for safety and security sensors. And as the low altitude economy takes off, hundreds of thousands of drones will perform a range of life-saving and commercial missions, requiring a sensor infrastructure to monitor airspace activity. The new 86,350-square-foot facility is a major step in readying supply for multiple, large, global markets. The
SCP Standard Capital Partners AG: Fabian Becker Appointed Chairman of the Management Board and CEO9.7.2026 15:51:00 EEST | Press release
The Supervisory Board of SCP Standard Capital Partners AG (WKN: A12UPJ | ISIN: DE000A12UPJ7 | XETRA ticker: CAP) resolved today to appoint Mr. Fabian Becker as Chairman of the Management Board and Chief Executive Officer (CEO), effective as of 9 July 2026. Ms. Stephanie Schettler-Köhler will remain a member of the Management Board and will assume the role of Chief Operating Officer (COO). View source version on businesswire.com: https://www.businesswire.com/news/home/20260709982268/en/
Teva and Polpharma Biologics Announce Global Licensing Agreement for a Biosimilar Candidate to Ocrevus ® (ocrelizumab) for Multiple Sclerosis9.7.2026 15:45:00 EEST | Press release
Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd (NYSE: and TASE: TEVA) and Polpharma Biologics International AG today announced a global licensing agreement granting Teva exclusive rights to commercialize both formulations of Polpharma Biologics’ proposed biosimilar to Ocrevus®1 (ocrelizumab), upon regulatory approval. This strategic agreement is expected to combine Polpharma Biologics’ proven biosimilar development expertise with Teva’s commercial footprint and capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260709701277/en/ “This agreement reflects our focus on pushing high-quality biologics to the finish line efficiently and at scale,” said Anjan Selz, Chief Executive Officer of Polpharma Biologics International AG. “Teva brings reach, discipline and real commercial strength to our strategic collaboration. Combining its global footprint with our technical and develo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom